Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Bryson

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Drugs|March 1, 1994
Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potentialH M Bryson, R N Brogden
Drugs|November 1, 1993
Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignanciesH M Bryson, E M Sorkin
Drugs|December 1, 1994
Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosisH M Bryson, E M Sorkin
Drugs|September 1, 1996
Quinupristin-dalfopristinH M Bryson, C M Spencer
Drugs|August 1, 1996
CidofovirA P Lea, H M Bryson
Drugs|March 1, 1994
Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic useL B Barradell, H M Bryson
Drugs|February 1, 1992
Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potentialH M Bryson, K L Goa
Drugs|April 1, 1997
Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depressionR Davis, R Whittington, H M Bryson
Drugs|October 1, 1996
Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosisH M Bryson, B Fulton, P Benfield
Drugs|April 1, 1997
Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infectionsK L Goa, H M Bryson, A Markham
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Drugs|March 1, 1994
Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potentialH M Bryson, R N Brogden
Drugs|November 1, 1993
Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignanciesH M Bryson, E M Sorkin
Drugs|December 1, 1994
Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosisH M Bryson, E M Sorkin
Drugs|September 1, 1996
Quinupristin-dalfopristinH M Bryson, C M Spencer
Drugs|August 1, 1996
CidofovirA P Lea, H M Bryson
Drugs|March 1, 1994
Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic useL B Barradell, H M Bryson
Drugs|February 1, 1992
Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potentialH M Bryson, K L Goa
Drugs|April 1, 1997
Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depressionR Davis, R Whittington, H M Bryson
Drugs|October 1, 1996
Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosisH M Bryson, B Fulton, P Benfield
Drugs|April 1, 1997
Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infectionsK L Goa, H M Bryson, A Markham
Pageof 5